Philippe Pinton

1.5k total citations · 1 hit paper
24 papers, 970 citations indexed

About

Philippe Pinton is a scholar working on Genetics, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Philippe Pinton has authored 24 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 8 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Philippe Pinton's work include Inflammatory Bowel Disease (7 papers), Microscopic Colitis (5 papers) and Acute Myocardial Infarction Research (5 papers). Philippe Pinton is often cited by papers focused on Inflammatory Bowel Disease (7 papers), Microscopic Colitis (5 papers) and Acute Myocardial Infarction Research (5 papers). Philippe Pinton collaborates with scholars based in Denmark, Japan and United States. Philippe Pinton's co-authors include Paul Barragan, Marie‐Claude Morice, Luc Maillard, Simon Elhadad, Gilles Montalescot, Olivier Wittenberg, Michel Pansiéri, P Villain, Rémi Choussat and Claude Lesty and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Philippe Pinton

21 papers receiving 916 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction

2001 800 citations Gilles Montalescot, Paul Barragan et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philippe Pinton Denmark	8	821	617	271	134	55	24	970
W. Niederer Germany	9	545 0.7×	302 0.5×	184 0.7×	169 1.3×	35 0.6×	20	681
Thomas Shimshak United States	23	1.2k 1.5×	1.1k 1.8×	557 2.1×	159 1.2×	70 1.3×	54	1.5k
Guillermo Aldama‐López Spain	15	397 0.5×	236 0.4×	162 0.6×	48 0.4×	23 0.4×	35	650
Zbigniew Chmielak Poland	16	747 0.9×	363 0.6×	229 0.8×	42 0.3×	55 1.0×	110	957
Thomas A. Kelly United States	11	1.0k 1.2×	627 1.0×	419 1.5×	74 0.6×	38 0.7×	24	1.1k
Yukinori Moriyama Japan	15	365 0.4×	333 0.5×	45 0.2×	59 0.4×	52 0.9×	94	754
Irving Franco United States	18	715 0.9×	828 1.3×	470 1.7×	46 0.3×	52 0.9×	39	1.0k
Youlan L. Gu Netherlands	13	606 0.7×	358 0.6×	275 1.0×	75 0.6×	30 0.5×	26	724
Dan-Mircea Olinic Romania	12	217 0.3×	354 0.6×	111 0.4×	86 0.6×	36 0.7×	69	591
Georgios E. Christakopoulos United States	15	452 0.6×	540 0.9×	446 1.6×	9 0.1×	48 0.9×	36	775

Countries citing papers authored by Philippe Pinton

Since Specialization

Citations

This map shows the geographic impact of Philippe Pinton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Pinton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Pinton more than expected).

Fields of papers citing papers by Philippe Pinton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Pinton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Pinton. The network helps show where Philippe Pinton may publish in the future.

Co-authorship network of co-authors of Philippe Pinton

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Pinton. A scholar is included among the top collaborators of Philippe Pinton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Pinton. Philippe Pinton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pinton, Philippe, et al.. (2025). Management of Recurrent Clostridioides difficile Infection (rCDI): A Systematic Literature Review to Assess the Feasibility of Indirect Treatment Comparison (ITC). Infectious Diseases and Therapy. 14(2). 327–355. 3 indexed citations

Allegretti, Jessica R., Paul Feuerstadt, W Knapple, et al.. (2025). Safety and Efficacy of Fecal Microbiota, Live-jslm (REBYOTA®), for the Prevention of Recurrent Clostridioides difficile Infection in Participants With Inflammatory Bowel Disease in PUNCH CD3-OLS. Inflammatory Bowel Diseases. 31(8). 2112–2122. 1 indexed citations

Pinton, Philippe. (2025). Gene Therapy for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: Current Evidence and Future Directions. Cancers. 17(22). 3631–3631.

Hisamatsu, Tadakazu, Makoto Naganuma, Philippe Pinton, & Mitsuhiro Takeno. (2024). Behçet’s disease: incidence, prevalence, and real-word data on the use of biologic agents in Japan. Journal of Gastroenterology. 60(3). 294–305.

Schreiber, Stefan G., et al.. (2024). Safety, tolerability, and pharmacokinetics of single‐ and multiple‐ascending doses of olamkicept: Results from randomized, placebo‐controlled, first‐in‐human phase I trials. Clinical and Translational Science. 17(5). e13832–e13832. 5 indexed citations

Pinton, Philippe. (2024). Machine Learning for Predicting Biologic Agent Efficacy in Ulcerative Colitis: An Analysis for Generalizability and Combination with Computational Models. Diagnostics. 14(13). 1324–1324. 1 indexed citations

Straube, Anne, Richard Stark, Laura Baxter, et al.. (2023). PGF2α induces a pro-labour phenotypical switch in human myometrial cells that can be inhibited with PGF2α receptor antagonists. Frontiers in Pharmacology. 14. 1285779–1285779. 1 indexed citations

Pinton, Philippe. (2023). Impact of artificial intelligence on prognosis, shared decision-making, and precision medicine for patients with inflammatory bowel disease: a perspective and expert opinion. Annals of Medicine. 55(2). 2300670–2300670. 18 indexed citations

Gabrielsen, Anette, et al.. (2023). Pre-Vitrification and Post-Warming Variables of Vitrified-Warmed Blastocysts That Are Predictable for Implantation. Journal of Clinical Medicine. 12(19). 6389–6389. 2 indexed citations

10.

Shao, Feng, Yi Jiang, Sijia Ding, et al.. (2022). Pharmacokinetics and Safety of Follitropin Delta in Gonadotropin Down-Regulated Healthy Chinese Women. Clinical Drug Investigation. 43(1). 37–44. 7 indexed citations

11.

Pinton, Philippe. (2022). Computational models in inflammatory bowel disease. Clinical and Translational Science. 15(4). 824–830. 10 indexed citations

12.

Nagahori, Masakazu, Kenji Watanabe, Satoshi Motoya, et al.. (2021). Week 2 Symptomatic Response with Vedolizumab as a Predictive Factor in Japanese Anti-TNFα-Naive Patients with Ulcerative Colitis: A post hoc Analysis of a Randomized, Placebo-Controlled Phase 3 Trial. Digestion. 102(5). 742–752. 10 indexed citations

13.

Kobayashi, Taku, Hiroaki Ito, Toshifumi Ashida, et al.. (2020). Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis. Intestinal Research. 19(4). 448–460. 10 indexed citations

14.

Hibi∥, Toshifumi, Isao Kamae, Philippe Pinton, et al.. (2020). Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis. Intestinal Research. 19(1). 53–61. 15 indexed citations

15.

Yu, Kyung‐Sang, Kyung Woo Park, Ronan P. Kelly, et al.. (2013). Pharmacokinetic and Pharmacodynamic Effects of Prasugrel in Healthy Korean Males. Journal of Cardiovascular Pharmacology. 62(1). 72–77. 7 indexed citations

16.

Montalescot, Gilles, Paul Barragan, Olivier Wittenberg, et al.. (2002). Primary stenting with abciximab in acute myocardial infarction complicated by cardiogenic shock (the ADMIRAL trial). Journal of the American College of Cardiology. 39. 43–43. 4 indexed citations

17.

Montalescot, Gilles, Paul Barragan, Olivier Wittenberg, et al.. (2001). Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction. New England Journal of Medicine. 344(25). 1895–1903. 800 indexed citations breakdown →

18.

Pinton, Philippe. (1998). [Abciximab-induced thrombopenia during treatment of acute coronary syndromes by angioplasty].. PubMed. 47(5). 351–8. 4 indexed citations

19.

Pinton, Philippe. (1998). [Abciximab in the treatment of acute coronary syndromes by angioplasty and stents].. PubMed. 53(4). 341–7. 1 indexed citations

20.

Pinton, Philippe, et al.. (1989). [Van der Woude syndrome].. PubMed. 124(4). 171–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact